The increase in cancer incidence and mortality is challenging current cancer care delivery globally, disproportionally affecting low- and middle-income countries (LMICs) when it comes to receiving evidence-based cancer prevention, treatment, and palliative and survivorship care. Patients in LMICs often rely on traditional, complementary, and integrative medicine (TCIM) that is more familiar, less costly, and widely available. However, spheres of influence and tensions between conventional medicine and TCIM can further disrupt efforts in evidence-based cancer care.
View Article and Find Full Text PDFargue that partnerships are key to building and sustaining health research capacity in Latin America
View Article and Find Full Text PDFThe region still needs to build its research capacity to inform effective public health policy and practices, say
View Article and Find Full Text PDFargue that development of research capacity in Latin America and the Caribbean requires investment in both individuals and regional institutions
View Article and Find Full Text PDF